Hope Alzheimer’s Center
At Hope Alzheimer’s Center, we are transforming how Alzheimer’s is diagnosed and treated — one image at a time.
Request an Appointment
Hope Alzheimer’s Center offers a complete and compassionate approach
Alzheimer’s often develops slowly and quietly over many years. Recognizing the early signs and getting evaluated can help individuals and families understand what’s happening and take the right steps forward.
A Window Into the Brain
At Hope Alzheimer’s, our Diagnostic Imaging services use the latest advancements in Nuclear Medicine and Molecular Imaging to detect Alzheimer’s disease early and guide personalized treatment plans.
Through Positron Emission Tomography (PET) imaging, we can visualize amyloid plaque in the brain — a key indicator believed to be linked to memory loss and cognitive decline. In many cases, amyloid buildup begins years before symptoms appear, making early detection essential for proactive care.
Our Molecular Imaging technology provides an in-depth look at brain structure and function, allowing our physicians to identify changes at the molecular level. This insight leads to more accurate diagnoses and individualized treatment strategies.
The Brain PET imaging process is minimally invasive and involves the use of a small amount of a radioactive tracer, which highlights areas of amyloid accumulation. This advanced imaging provides a clearer understanding of each patient’s condition and helps inform targeted therapy decisions.
With proven clinical value, Amyloid Brain Imaging is now CMS-approved, reflecting its importance in the early detection and management of Alzheimer’s disease.
At Hope Alzheimer’s, we are transforming how Alzheimer’s is diagnosed and treated — one image at a time.
Targeted Treatment for Alzheimer’s Disease
At Hope Alzheimer’s, we are leading the way in the treatment of Alzheimer’s disease through Targeted Monoclonal Infusion Therapy — an innovative approach designed to remove amyloid plaque from the brain, which scientists believe is a primary contributor to the onset and progression of dementia and Alzheimer’s disease.
For the first time, we now have FDA-approved therapies that address the underlying cause of Alzheimer’s — not just the symptoms.
Our infusion treatments include:
In clinical trials, patients receiving these therapies demonstrated up to a 35% improvement in cognitive outcomes, representing a significant advancement in slowing disease progression.
These treatments are CMS and Medicare approved, making them accessible to more patients seeking proactive, science-driven care.
At Hope Alzheimer’s, our compassionate infusion team delivers these treatments in a safe, comfortable environment — combining advanced medicine with personalized support for every patient and family.
At Hope Alzheimer’s, we also provide Cardiac PET Imaging — an advanced, noninvasive tool that evaluates blood flow and function of the heart. Using molecular imaging, Cardiac PET helps detect coronary artery disease (CAD), assess myocardial viability, and guide personalized treatment plans.
This powerful diagnostic service offers clearer images, faster results, and improved accuracy compared to traditional stress tests — giving patients and physicians confidence in every diagnosis.
Take steps toward a future without Alzheimer’s.
Find a walk near you.
Hope Diagnostic Imaging: 405-832-4673
Hope Alzheimer's Center: 405-516-4673
Hope Diagnostic Fax: 405-254-0274
Hope Alzheimer's Fax: 572-229-6680
Email: info@hope-alzheimers.com
Address: 3300 NW 56th St, Oklahoma City, OK 73112
Hours: M-F 8am-5pm
